308 related articles for article (PubMed ID: 22540861)
1. Significant endothelin release in patients treated with foam sclerotherapy.
Frullini A; Barsotti MC; Santoni T; Duranti E; Burchielli S; Di Stefano R
Dermatol Surg; 2012 May; 38(5):741-7. PubMed ID: 22540861
[TBL] [Abstract][Full Text] [Related]
2. Preliminary experience with a new sclerosing foam in the treatment of varicose veins.
Tessari L; Cavezzi A; Frullini A
Dermatol Surg; 2001 Jan; 27(1):58-60. PubMed ID: 11231246
[TBL] [Abstract][Full Text] [Related]
3. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
Uncu H
Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
[TBL] [Abstract][Full Text] [Related]
4. An investigation of coagulation cascade activation and induction of fibrinolysis using foam sclerotherapy of reticular veins.
Fabi SG; Peterson JD; Goldman MP; Guiha I
Dermatol Surg; 2012 Mar; 38(3):367-72. PubMed ID: 22092650
[TBL] [Abstract][Full Text] [Related]
5. Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications.
Frullini A; Cavezzi A
Dermatol Surg; 2002 Jan; 28(1):11-5. PubMed ID: 11991262
[TBL] [Abstract][Full Text] [Related]
6. Stability of foam in sclerotherapy: differences between sodium tetradecyl sulfate and polidocanol and the type of connector used in the double-syringe system technique.
Rao J; Goldman MP
Dermatol Surg; 2005 Jan; 31(1):19-22. PubMed ID: 15720090
[TBL] [Abstract][Full Text] [Related]
7. Complications and side-effects of foam sclerotherapy.
Guex JJ
Phlebology; 2009 Dec; 24(6):270-4. PubMed ID: 19952383
[TBL] [Abstract][Full Text] [Related]
8. High production of endothelin after foam sclerotherapy: a new pathogenetic hypothesis for neurological and visual disturbances after sclerotherapy.
Frullini A; Felice F; Burchielli S; Di Stefano R
Phlebology; 2011 Aug; 26(5):203-8. PubMed ID: 21478144
[TBL] [Abstract][Full Text] [Related]
9. Double-blind prospective comparative trial between foamed and liquid polidocanol and sodium tetradecyl sulfate in the treatment of varicose and telangiectatic leg veins.
Rao J; Wildemore JK; Goldman MP
Dermatol Surg; 2005 Jun; 31(6):631-5; discussion 635. PubMed ID: 15996411
[TBL] [Abstract][Full Text] [Related]
10. Polidocanol concentration and time affect the properties of foam used for sclerotherapy.
VAN Deurzen B; Ceulen RP; Tellings SS; VAN DER Geld C; Nijsten T
Dermatol Surg; 2011 Oct; 37(10):1448-55. PubMed ID: 21790848
[TBL] [Abstract][Full Text] [Related]
11. Sclerotherapy of varicose veins with polidocanol based on the guidelines of the German Society of Phlebology.
Rabe E; Pannier F
Dermatol Surg; 2010 Jun; 36 Suppl 2():968-75. PubMed ID: 20590702
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of duplex-guided foam sclerotherapy and duplex-guided liquid sclerotherapy for the treatment of superficial venous insufficiency.
Yamaki T; Nozaki M; Iwasaka S
Dermatol Surg; 2004 May; 30(5):718-22; discussion 722. PubMed ID: 15099313
[TBL] [Abstract][Full Text] [Related]
13. Physiochemical properties and reproducibility of air-based sodium tetradecyl sulphate foam using the Tessari method.
Watkins MR; Oliver RJ
Phlebology; 2017 Jul; 32(6):390-396. PubMed ID: 27329670
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of sodium tetradecyl sulfate and polidocanol as sclerosants for leg telangiectasia based on histological evaluation with clinical correlation.
Bush R; Bush P
Phlebology; 2017 Aug; 32(7):496-500. PubMed ID: 27738241
[TBL] [Abstract][Full Text] [Related]
15. Changes in venous function after foam sclerotherapy of varicose veins.
Brunken A; Rabe E; Pannier F
Phlebology; 2009 Aug; 24(4):145-50. PubMed ID: 19620696
[TBL] [Abstract][Full Text] [Related]
16. Venous disorders: treatment with sclerosant foam.
Bergan J; Pascarella L; Mekenas L
J Cardiovasc Surg (Torino); 2006 Feb; 47(1):9-18. PubMed ID: 16434941
[TBL] [Abstract][Full Text] [Related]
17. Foam sclerotherapy: an overview of use for primary venous insufficiency.
Guex JJ
Semin Vasc Surg; 2005 Mar; 18(1):25-9. PubMed ID: 15791550
[TBL] [Abstract][Full Text] [Related]
18. Sclerotherapy of telangiectases and reticular veins: a double-blind, randomized, comparative clinical trial of polidocanol, sodium tetradecyl sulphate and isotonic saline (EASI study).
Rabe E; Schliephake D; Otto J; Breu FX; Pannier F
Phlebology; 2010 Jun; 25(3):124-31. PubMed ID: 20483861
[TBL] [Abstract][Full Text] [Related]
19. A Review of Sclerosing Foam Stability in the Treatment of Varicose Veins.
Bai T; Liu Y; Jiang W; Li Y; Liu J; Yu C; Fan Y
Dermatol Surg; 2020 Feb; 46(2):249-257. PubMed ID: 31569112
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of polidocanol foam versus liquid in sclerotherapy of the great saphenous vein: a multicentre randomised controlled trial with a 2-year follow-up.
Ouvry P; Allaert FA; Desnos P; Hamel-Desnos C
Eur J Vasc Endovasc Surg; 2008 Sep; 36(3):366-70. PubMed ID: 18524643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
